OPERA: a phase II study of DHP107 (oral paclitaxel) versus intravenous paclitaxel in patients with HER2-negative recurrent or metastatic breast cancer

20260 citationsJournal Articlehybrid Open Access

Authors

gov no: NCT03326102; date of registration October 19, 2017.

Good health and well-being

Published in: Breast Cancer Research and Treatment

Volume 217, Issue 1

Field-Weighted Citation Impact: 0.00